Entropy Technologies’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Buy
+41,676
New +$1.06M 0.03% 587
2024
Q4
– Sell
-13,750
Closed -$207K – 926
2024
Q3
$207K Buy
+13,750
New +$235K 0.02% 631

Other funds holding PCRX

Entropy Technologies's PCRX Position: Q3 2026 in Review

Entropy Technologies opened a new position in Pacira BioSciences (PCRX) in Q3 2026: 41,676 shares worth $1.04M. The stake represents 0.03% of the portfolio and ranks #587 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in PCRX as recently as Q3 2024.

Entropy Technologies first reported a position in PCRX in Q3 2024 and has held it in 2 quarters since. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Entropy Technologies held 41,676 shares of Pacira BioSciences worth $1.04M as of Q3 2026.
  • Pacira BioSciences was a new Entropy Technologies position in Q3 2026.
  • Pacira BioSciences made up 0.03% of Entropy Technologies's portfolio in Q3 2026, its #587 holding.
  • Entropy Technologies first reported a position in Pacira BioSciences in Q3 2024 and has held it in 2 quarters since.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Entropy Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.